Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 1/20 | 0.57 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.57 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.57 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.57 |
| ▸ | THRA | P10827 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10427981 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3LPAR2THRA | |
| SCHEMBL2820207 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3LPAR2THRA | |
| SCHEMBL277697 | 0.98 | S1PR2 (0.55) | S1PR2S1PR1S1PR3LPAR2THRA | |
| SCHEMBL579348 | 0.94 | NPC1 (0.54) | S1PR2S1PR1S1PR3LPAR2NPC1 | |
| SCHEMBL13398989 | 0.92 | S1PR1 (0.51) | S1PR2S1PR1S1PR3LPAR2SMPD1 | |
| SCHEMBL10996676 | 0.92 | S1PR1 (0.51) | S1PR2S1PR1S1PR3LPAR2SMPD1 | |
| SCHEMBL8846068 | 0.92 | S1PR1 (0.51) | S1PR2S1PR1S1PR3LPAR2SMPD1 | |
| SCHEMBL1238817 | 0.92 | S1PR1 (0.51) | S1PR2S1PR1S1PR3LPAR2SMPD1 | |
| SCHEMBL9706223 | 0.92 | POLB (0.57) | S1PR2S1PR1S1PR3LPAR2NPC1 | |
| SCHEMBL8845989 | 0.90 | S1PR1 (0.49) | S1PR2S1PR1S1PR3LPAR2SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115721567-A | Thermal wet tissue and preparation method thereof | 芜湖悠派护理用品科技股份有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-111962292-A | Spontaneous heating material body and spontaneous heating activated carbon non-woven fabric hair cap | 上海创始实业（集团）有限公司 | 2020-11-20 | — | — | CN | claimed |
| CN-104887581-B | A kind of oral care composition and preparation method thereof | 云南天美天康生物科技有限公司 | 2018-02-23 | — | — | CN | claimed |
| EP-2742983-B1 | Method for isolating fragrance and flavour compounds | SYMRISE AG (DE) | 2017-08-23 | — | — | EP | claimed |
| CN-105473002-A | 1H-PYRROLE-2,4-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS | FRESENIUS KABI DE GMBH | 2016-04-06 | — | — | CN | claimed |
| EP-2742983-A1 | Method for isolating fragrance and flavour compounds | Symrise AG (DE) | 2014-06-18 | — | — | EP | claimed |
| US-20140113971-A1 | Topical NSAID Compositions Having Sensate Component | ZHANG JOANNA (US) | 2014-04-24 | — | — | US | claimed |
| US-20110237674-A1 | TOPICAL NSAID COMPOSITIONS HAVING SENSATE COMPONENT | NOVARTIS AG (CH) | 2011-09-29 | — | — | US | claimed |
| EP-2349248-A2 | TOPICAL NSAID COMPOSITIONS HAVING SENSATE COMPONENT | Novartis AG (CH) | 2011-08-03 | — | — | EP | claimed |
| WO-2010045415-A2 | TOPICAL NSAID COMPOSITIONS HAVING SENSATE COMPONENT | NOVARTIS AG (CH) | 2010-04-22 | — | — | WO | claimed |
| EP-0977554-B1 | CONFECTIONERY COMPOSITIONS | PROCTER & GAMBLE (US) | 2004-06-16 | — | — | EP | claimed |
| EP-0977553-B1 | THROAT SOOTHING COMPOSITIONS | PROCTER & GAMBLE (US) | 2003-09-10 | — | — | EP | claimed |
| US-6432441-B1 | ENCAPSULATION OF ANALGESICS, EXPECTORANTS OR ANTITUSSIVE AGENTS WITHIN PHOSPHATIDES TO PROLONG DRUG DELIVERY | THE PROCTER & GAMBLE COMPANY | 2002-08-13 | — | — | US | claimed |
| US-6306429-B1 | THROAT DROPS SUITABLE FOR RELIEF OF COUGH AND COLD SYMPTOMS | THE PROCTER & GAMBLE COMPANY | 2001-10-23 | — | — | US | claimed |
| EP-0977554-A1 | CONFECTIONERY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-09 | — | — | EP | claimed |
| EP-0977553-A1 | THROAT SOOTHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1998047483-A1 | CONFECTIONERY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | claimed |
| WO-1998047482-A1 | THROAT SOOTHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | claimed |
| EP-0837862-A1 | WARMING COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-29 | — | — | EP | claimed |
| WO-1997002273-A1 | WARMING COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237674-A1 | TOPICAL NSAID COMPOSITIONS HAVING SENSATE COMPONENT | TRPA1, TRPV1, PTGES | S1PR2 2789/4885S1PR1 2374/4885S1PR3 2106/4885 |
| US-20140113971-A1 | Topical NSAID Compositions Having Sensate Component | TRPA1, TRPV1, PTGES | S1PR2 2789/4885S1PR1 2374/4885S1PR3 2106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.